A COMBINATION OF FBPASE INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES - Patent 1372660

(19)

(11)

EP 1 372 660 A2

(12)

(88)	Date of publication A3:
	16.10.2003

(43)	Date of publication:
	02.01.2004 Bulletin 2004/01

(21)	Application number: 01952530.2

(22)	Date of filing: 05.07.2001

(51)	International Patent Classification (IPC)⁷: A61K 31/52, A61K 31/675, A61K 31/64, A61P 5/00

(86)	International application number:
	PCT/US2001/021557

(87)	International publication number:
	WO 2002/003978 (17.01.2002 Gazette 2002/03)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

06.07.2000 US 216531 P

(71)	Applicants:
	Metabasis Therapeutics, Inc. San Diego, CA 92121 (US) Sankyo Company, Limited Tokyo 140-8710 (JP)

(72)	Inventors:
	VAN POELJE, Paul, D. La Jolla, CA 92037 (US) ERION, Mark, D. Del Mar, CA 92014 (US) FUJIWARA, Toshihiko,Sankyo Company, Limited Shinagawa-ku,Tokyo 140-8710 (JP)

(74)	Representative: Sexton, Jane Helen
	J.A. KEMP & CO.14 South SquareGray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(54)	A COMBINATION OF FBPASE INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES